Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: A self-controlled prospective study

Archives of Dermatology

Volumn 134, Issue 8, 1998, Pages 940-945

  Gelfand, Joel M ^a   Rudikoff, Donald ^b   Lebwohl, Mark ^b   Klotman, Mary E ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RNA VIRUS; ULTRAVIOLET B RADIATION; VIREMIA; VIRUS REPLICATION;

EID: 0031904775     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.8.940     Document Type: Article

References (50)

1. Duvic M. Human immunodeficiency virus and the skin: selected controversies. J Invest Dermatol. 1995;105(suppl):117S-121S.
2. Adams ML, Houpt KR, Cruz PD. Is phototherapy safe for HIV-infected individuals? Photochem Photobiol. 1996;64:234-237.
3. Vincek V. Sunlight-induced progression of AIDS. Med Hypotheses. 1995;44:119-123.
4. Duan Y, Kennedy SB. Review of the impact on the activation of HIV-1 by UV light. Med Hypotheses. 1996;47:11-14.
5. Houpt KR, Beer JZ, Horn TD, Moy JA, Zmudzka BZ, Cruz PD Jr. Ultraviolet therapy of HIV-infected individuals. Semin Cutan Med Surg. 1997;16:241-245.
6. Beer JZ, Zmudzka BZ. UVB and PUVA therapies in HIV patients: are they safe? Photodermatol Photoimmunol Photomed. 1997;13:91-92.
7. Valerie K, Delers A, Bruck C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988;333:78-81.
8. Stanley SK, Folks TM, Fauci A. Induction of expression of HIV in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses. 1989;5:375-384.
9. Morrey JD, Bourn SM, Bunch TD, et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen, and UV-B light in the skin of transgenic mice. J Virol. 1991;65:5045-5051.
10. Vogel J, Cepeda M, Tschachler E, Napolitano LA, Jay G. UV activation of human immunodeficiency virus gene expression in transgenic mice. J Virol. 1992;66:1-5.
11. Cavard C, Zider A, Vernet M, et al. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest. 1990; 86:1369-1374.
12. Frucht DM, Lamperth L, Vicenzi E, Belcher JH, Martin MA. Ultraviolet radiation increases HIV-long terminal repeat-directed expression in transgenic mice. AIDS Res Hum Retroviruses. 1991;7:729-733.
13. Sadaie MR, Tschachler E, Valerie K, et al. Activation of tat-defective HIV by ultraviolet light. New Biologist. 1990;2:479-486.
14. Horn TD, Morison WL, Farzadegan H, Zmudzka BZ, Beer JZ. Effect of psoralen plus UVA radiation (PUVA) on HIV-1 in human beings: a pilot study. J Am Acad Dermatol. 1994;31(pt 1):735-740.
15. Beer JZ, Zmudzka BZ. Effects of UV on HIV and other infections. Photochem Photobiol. 1996;64:231-233.
16. Kanitakis J, Escaich S, Trepo C, Thivolet J. Detection of human immunodeficiency virus-1 DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol. 1991;97:91-96.
17. Zmudzka BZ, Miller SA, Jacobs ME, Beer JZ. Medical UV exposures and HIV activation. Photochem Photobiol. 1996;64:246-253.
18. Stingl G, Rappersberger K, Tschachler E, et al. Langerhans cells in HIV-1 infection. J Am Acad Dermatol. 1990;22:1210-1217.
19. Burnham K, Pickard S, Hudson J, Voss T. Requirements for Langerhans' cell depletion following in vitro exposure of murine skin to UVB. Immunology. 1993;79: 627-632.
20. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol. 1995;32:53-62.
21. Granstein RD. Photoimmunology. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austin KF, eds. Dermatology in General Medicine. New York, NY: Mc-Graw Hill Book Co: 1993:1643-1650.
22. Urbanski A, Schwartz T, Neuner P, et al. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol. 1990;94:808-811.
23. Konnikov N, Pincus SH, Dinarello CA. Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Dermatol. 1989;92:235-239.
24. Duvic M, Breuer-McHam J, Marshall G, et al. UV light dosage influences HIV and IL-10 cytokine expression in AIDS patients [abstract]. J Invest Dermatol. 1997; 108:556A.
25. Hersey P, Bradley M, Hasic E, Haran G, Edwards A, McCarthy WH. Immunological effects of solarium exposure. Lancet. 1983;1:545-548.
26. Morrison WL, Parrish JA, Bloch KJ. In vivo effect of UVB on lymphocyte function. Br J Dermatol. 1979;101:513-519.
27. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with HIV. Arch Dermatol. 1989;125:357-361.
28. Beer JZ, Mills DK, Zmudzka BZ, et al. The use of UV therapies for treatment of skin conditions in HIV-infected patients. Photochem Photobiol. 1997;65(suppl):93S.
29. Meola T, Soter NA, Ostreicher R, Sanchez M, Moy JA. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol. 1993;29(pt 1):216-220.
30. Duvic M, Ulmer M, Crane M, et al. Treatment of HIV + patients with UVB is associated with a significant increase in p24 antigen levels. Photochem Photobiol. 1995;61(suppl abstract):61SA.
31. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo. Science. 1996;271:1582-1586.
32. Ho DD. Viral counts count in HIV infection. Science. 1996;272:1124-1125.
33. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4 + lymphocyte counts and the risk of progression to AIDS: Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 1996;334:426-431.
34. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
35. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267:483-489.
36. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA. 1995;274:554-558.
37. Greenblatt R, Weider E, Karliner L, et al. HIV-1 RNA levels and expression of immune activation markers among adults during common acute infections and convalescence. In: Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections; January 1997; Washington, DC. Abstract 116.
38. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1 infected individuals. J Exp Med. 1995;182:1727-1737.
39. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood. 1995;86:1082-1089.
40. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med. 1996;334:1222-1230.
41. Brichacek B, Swindells S, Janoff EN, Pirruccello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis. 1996;174:1191-1199.
42. Saag MS, Holodniy M, Kuritzkes DR, etal. HIV viral load markers in clinical practice. Nat Med. 1996;2:625-629.
43. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature. 1997;387:188-191.
44. Duo LJ. Electric needle therapy of uremic pruritus. Nephron. 1987;47:179-183.
45. Pardo RJ, Bogaert MA, Penneys NS, Byrne GE Jr, Ruiz P. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol. 1992;26:423-428.
46. Machin D, Cambell MJ. Statistical Tables for the Design of Clinical Trials. Boston, Mass: Blackwell Scientific Publications; 1987.
47. Fotiades J, Soter NA, Sanchez MR, Moy JA. A three-year follow-up on 28 HIV positive patients treated with UVB phototherapy [abstract]. J Invest Dermatol. 1995;104:660A.
48. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co Inc; 1997: 2368-2371.
49. Saah AJ, Horn TD, Hoover DR, et al. Solar ultraviolet radiation exposure does not appear to exacerbate HIV infection in gay men. In: Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections; 1996; Washington, DC. Abstract 99 (available at: http://www.idsociety.org/abst/99.HTM).
50. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA. 1997;277:1962-1969.